Intelivation Technologies09.24.21
Intelivation Technologies, a medical device company with a growing product portfolio, will officially launch the Advantage-C PEEK Cervical Interbody Fusion Device at the 36th Annual NASS Meeting in Boston (Sept. 29-Oct. 2).
The Advantage-C Device received U.S. Food and Drug Administration (FDA) 510(k) clearance earlier this month. The Advantage-C Device is designed to be used in skeletally mature patients in levels C2-T1 in conjunction with fixation for ACDF (anterior cervical discectomy and fusion) procedures. Advantage-C was developed to optimize fusion, while maintaining elasticity that is similar to bone and radiolucency of the cage body.
Intelivation Technologies President Amit Sinha stated, “I am excited about the FDA Approval of Advantage-C and the myriad of efficiencies this device will bring to both surgeons and hospital systems alike.”
“Our growing line of interbody devices further drives home our commitment to innovating cost-effective spinal solutions that consistently provide superior clinical results, and the management team looks forward to a successful launch during the 36th Annual NASS Meeting in Boston,” CEO Rob Anderson added.
Intelivation Technologies, headquartered in Saint Simons Island, Ga., and dedicated to research and development, is focused on bringing game-changing products to market that make patients’ lives better.
The Advantage-C Device received U.S. Food and Drug Administration (FDA) 510(k) clearance earlier this month. The Advantage-C Device is designed to be used in skeletally mature patients in levels C2-T1 in conjunction with fixation for ACDF (anterior cervical discectomy and fusion) procedures. Advantage-C was developed to optimize fusion, while maintaining elasticity that is similar to bone and radiolucency of the cage body.
Intelivation Technologies President Amit Sinha stated, “I am excited about the FDA Approval of Advantage-C and the myriad of efficiencies this device will bring to both surgeons and hospital systems alike.”
“Our growing line of interbody devices further drives home our commitment to innovating cost-effective spinal solutions that consistently provide superior clinical results, and the management team looks forward to a successful launch during the 36th Annual NASS Meeting in Boston,” CEO Rob Anderson added.
Intelivation Technologies, headquartered in Saint Simons Island, Ga., and dedicated to research and development, is focused on bringing game-changing products to market that make patients’ lives better.